Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares Total Assets
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares total assets. Based on the latest financial reports, Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) holds total assets worth $12.84 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see HKPD market cap for the company's overall valuation and market capitalisation.
Total Assets of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (2023–2026)
Total assets of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares from 2023 to 2026. This chart illustrates how Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's total assets have evolved over time, based on quarterly financial data. See HKPD live share price for real-time trading data and today's change.
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares - Asset Composition Analysis
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares Total Assets Breakdown (March 2026)
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares total assets breakdown as of March 2026. Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's total assets of $12.84 Million consist of 96.0% current assets and 4.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 1.7% |
| Accounts Receivable | $3.80 Million | 29.6% |
| Inventory | $360.11K | 2.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $76.64K | 0.6% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2023–2026)
This chart illustrates how Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore HKPD net working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's current assets represent 96.0% of total assets in 2026, an increase from 80.7% in 2023.
- Cash Position: Cash and equivalents constituted 1.7% of total assets in 2026, down from 15.4% in 2023.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2023.
- Asset Diversification: The largest asset category is accounts receivable at 29.6% of total assets.
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares Competitors by Total Assets
Key competitors of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368
|
China | CN¥21.18 Billion |
|
TELES Informationstechnologien AG
XETRA:TLIK
|
Germany | €4.29 Million |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$8.80 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
China | CN¥240.77 Billion |
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.86 | 2.99 | 2.46 |
| Quick Ratio | 3.75 | 2.80 | 2.16 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $9.14 Million | $5.81 Million | $4.63 Million |
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares - Advanced Valuation Insights
This section examines the relationship between Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.65 |
| Latest Market Cap to Assets Ratio | 0.46 |
| Asset Growth Rate (YoY) | 36.4% |
| Total Assets | $12.84 Million |
| Market Capitalization | $5.95 Million USD |
Valuation Analysis
Below Book Valuation: The market values Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's assets below their book value (0.46x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's assets grew by 36.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (2023–2026)
The table below shows the annual total assets of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares from 2023 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | $12.84 Million | +36.39% |
| 2025-03-31 | $9.42 Million | +8.65% |
| 2024-03-31 | $8.67 Million | +154.41% |
| 2023-03-31 | $3.41 Million | -- |
About Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers customs clearance, drugs enlisting, warehouse, and other logistics services. In addition, it provides valu… Read more